DM Arena URO/Oncology

Dato:  Tirsdag 4. september 2018, Oslo Norway kl. 17.00-20.00

Registrering og enkel servering fra kl. 16.30

Sted: Oslo Cancer Cluster, Ullernchausséen 64 (close to Radiumhospitalet)

Kaare Norum Auditorium

Dette DM Arena-møtet er, på grunn av begrenset plass, lukket for legemiddelindustrien og andre kommersielle aktører – med mindre man er sponsor.

16.30: Registration, Coffee and snacks

17.00: Welcome: by Markus Moe (Dagens Medisin)

17.05: Introduction: Jan Oldenburg (Ahus)

17.10: State of the art – trimodal treatment of bladder cancer (last opp)

Prof. Nick James (Professor of Clinical Oncology, Institute of Cancer and Genomic Sciences, University of Birmingham)

(30min talk +10min Q&A)

17.50: Indication for - and timing of cytoreductive nephrectom, Kidney- and bladder cancer: Immunotherapy (last ned)

Prof. Axel Bex, EORTC GU Director, Department of Urology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands

(30min talk +10min Q&A)

18.30: Break:  coffee & snacks (10 min)

18.40: Significant tumors of the prostate: Visualization by ultrasound versus mpMRI and their limitations

Prof. Tillmann Loch, Department of Urology, Diakonissenkrankenhaus Flensburg, Lehrkrankenhaus der Christian-Albrechts-Universität, Marienhölzungsweg, Flensburg, Germany

(30min talk +10min Q&A)

19.20: Treatment of prostate cancer with focus on results from STAMPEDE (last ned)

Prof. Nick James (Professor of Clinical Oncology, Institute of Cancer and Genomic Sciences, University of Birmingham)

(30min talk +10min Q&A)

20.00: End

Sponsorer: